Sicagen India Latest Share Price (SICAGEN)
TODAY IN ONE LINE
SICAGEN dropped 3.8%, lagging Nifty's -0.1% move, with no exchange filing today, suggesting a market-driven move.
With a market cap of ₹212.1 Cr., it trades at a P/E of 11.41. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Sicagen India flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Quarterly OutperformanceLatest quarter Sales up 10.5% and Profit up 12.3%
- ●Reasonable ValuationTrading at a moderate P/E of 12.6x
- ●High Promoter HoldingPromoters hold 61.1% skin-in-the-game
- ●Steady Dividend YieldReliable 1.91% dividend yield
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Poor Capital ReturnsLow ROE of 3.7%
Latest Sicagen India News
What changed recently?
Recent events, corporate actions, and announcements.
Sicagen India Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Sicagen India Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Sicagen India Ltd trades at a P/E of 11.41× and P/B of 0.47×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Sicagen India Ltd technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for Sicagen India Ltd — derived from the latest tape, not yesterday's close.
Sicagen India Ltd last traded at ₹53.55 with an intraday range of ₹52.88–₹57 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹53.55| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 64.31 | +10.76 | +20.10% |
| R3 | 60.19 | +6.64 | +12.41% |
| R2 | 58.60 | +5.05 | +9.42% |
| R1 | 56.07 | +2.52 | +4.71% |
| PIVOT | 54.48 | 0.93 | 1.73% |
| CURRENT | 53.55 | — | — |
| S1 | 51.95 | -1.60 | -2.98% |
| S2 | 50.36 | -3.19 | -5.96% |
| S3 | 47.83 | -5.72 | -10.68% |
| S4 | 43.71 | -9.84 | -18.37% |
SICAGEN is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹53.41–₹57
Trading Below opening range, showing Bearishness
Sicagen India Ltd financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Sicagen India Ltd — consolidated or standalone — with margins, YoY growth and key ratios inline.
Sicagen India Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹212.1 Cr. and reported EPS of ₹4.57.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 892 | 973 ▲ 9.1% |
| Sales Growth YoY %Derived | 12.12% | 9.15% |
| Other Income | 8 | 10 ▲ 21.3% |
| Total Income | 900 | 983 ▲ 9.3% |
| 790 | 861 ▲ 9.0% | |
| Gross ProfitDerived | 102 | 113 ▲ 10.5% |
| Gross Margin %Derived | 11.45% | 11.59% |
| 67 | 74 ▲ 10.4% | |
| EBITDA (Operating Profit)Derived | 36 | 39 ▲ 10.7% |
| OPM %Derived | 3.98% | 4.04% |
| 24 | 23 ▼ 1.9% | |
| Profit Before Tax (PBT) | 24 | 25 ▲ 4.4% |
| 7 | 7 ▲ 1.6% | |
| Effective Tax %Derived | 29.24% | 28.44% |
| Total Profit for Period | 17 | 18 ▲ 5.6% |
| Net Profit (Owner's PAT)Derived | 17 | 18 ▲ 5.6% |
| Net Profit Margin %Derived | 1.92% | 1.86% |
| PAT Growth YoY %Derived | 63.11% | 5.61% |
| Earnings Per Share (EPS ₹) | 4.32 | 4.57 ▲ 5.8% |
| Diluted Shares Outstanding (Cr) | 4 | 4 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | 6 | -23 ▼ 487.3% |
| Total Expenses (incl. D&A & Interest) | 876 | 958 ▲ 9.4% |
| Material Cost % of RevenueDerived | 38.51% | 47.13% |
| Employee Cost % of RevenueDerived | 3.22% | 3.18% |
| Other Cost % of RevenueDerived | 4.25% | 4.37% |
| Interest Coverage (x)Derived | 2.27x | 2.24x |
| Period | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 740 | 820 ▲ 10.9% | 699 ▼ 14.8% | 542 ▼ 22.5% | 836 ▲ 54.4% | 895 ▲ 7.1% | 795 ▼ 11.2% | 892 ▲ 12.1% | 973 ▲ 9.1% | |
| Sales Growth YoY %Derived | — | 10.87% | -14.81% | -22.50% | 54.37% | 7.08% | -11.15% | 12.12% | 9.15% | |
| Other Income | 15 | 17 ▲ 13.9% | 11 ▼ 34.2% | 8 ▼ 24.2% | 9 ▲ 2.7% | 8 ▼ 4.8% | 7 ▼ 13.3% | 8 ▲ 13.5% | 10 ▲ 21.3% | |
| Total Income | 755 | 837 ▲ 10.9% | 710 ▼ 15.2% | 550 ▼ 22.5% | 845 ▲ 53.6% | 903 ▲ 7.0% | 803 ▼ 11.2% | 900 ▲ 12.1% | 983 ▲ 9.3% | |
652 | 731 ▲ 12.1% | 620 ▼ 15.1% | 477 ▼ 23.1% | 761 ▲ 59.6% | 810 ▲ 6.3% | 711 ▼ 12.2% | 790 ▲ 11.1% | 861 ▲ 9.0% | ||
| Gross ProfitDerived | 88 | 90 ▲ 1.8% | 79 ▼ 12.3% | 65 ▼ 17.9% | 75 ▲ 15.6% | 86 ▲ 14.8% | 85 ▼ 1.2% | 102 ▲ 20.6% | 113 ▲ 10.5% | |
| Gross Margin %Derived | 11.91% | 10.93% | 11.26% | 11.93% | 8.93% | 9.58% | 10.64% | 11.45% | 11.59% | |
87 | 88 ▲ 1.3% | 67 ▼ 23.7% | 56 ▼ 16.7% | 53 ▼ 6.1% | 59 ▲ 12.3% | 58 ▼ 2.9% | 67 ▲ 15.8% | 74 ▲ 10.4% | ||
| EBITDA (Operating Profit)Derived | 1 | 1 ▲ 41.2% | 11 ▲ 686.1% | 8 ▼ 25.2% | 22 ▲ 159.1% | 27 ▲ 20.8% | 27 ▲ 2.5% | 36 ▲ 30.7% | 39 ▲ 10.7% | |
| OPM %Derived | 0.14% | 0.18% | 1.62% | 1.56% | 2.63% | 2.96% | 3.41% | 3.98% | 4.04% | |
14 | 15 ▲ 9.1% | 19 ▲ 23.3% | 15 ▼ 18.7% | 8 ▼ 47.3% | 26 ▲ 217.5% | 20 ▼ 20.8% | 24 ▲ 15.9% | 23 ▼ 1.9% | ||
| Profit Before Tax (PBT) | 2 | 3 ▲ 72.1% | 3 ▲ 20.1% | 1 ▼ 57.8% | 5 ▲ 247.9% | 22 ▲ 331.9% | 14 ▼ 36.0% | 24 ▲ 74.7% | 25 ▲ 4.4% | |
1 | 3 ▲ 442.0% | 3 ▲ 12.5% | 5 ▲ 52.1% | 6 ▲ 21.1% | 4 ▼ 32.0% | 3 ▼ 12.3% | 7 ▲ 111.0% | 7 ▲ 1.6% | ||
| Effective Tax %Derived | 30.30% | 95.42% | 89.44% | 322.22% | 112.18% | 17.65% | 24.21% | 29.24% | 28.44% | |
| Total Profit for Period | 1 | 0 ▼ 88.7% | 0 ▲ 176.9% | -3 ▼ 988.9% | -1 ▲ 80.9% | 18 ▲ 3021.3% | 10 ▼ 41.1% | 17 ▲ 63.1% | 18 ▲ 5.6% | |
| Net Profit (Owner's PAT)Derived | 1 | 0 ▼ 88.7% | 0 ▲ 176.9% | -3 ▼ 988.9% | -1 ▲ 80.9% | 18 ▲ 3021.3% | 10 ▼ 41.1% | 17 ▲ 63.1% | 18 ▲ 5.6% | |
| Net Profit Margin %Derived | 0.16% | 0.02% | 0.05% | -0.59% | -0.07% | 1.99% | 1.32% | 1.92% | 1.86% | |
| PAT Growth YoY %Derived | — | -88.70% | 176.92% | -988.89% | 80.94% | 3,021.31% | -41.13% | 63.11% | 5.61% | |
| Earnings Per Share (EPS ₹) | 0.29 | 0.03 ▼ 89.7% | 0.09 ▲ 200.0% | -0.81 ▼ 1000.0% | -0.15 ▲ 81.5% | 4.50 ▲ 3100.0% | 2.65 ▼ 41.1% | 4.32 ▲ 63.0% | 4.57 ▲ 5.8% | |
| Diluted Shares Outstanding (Cr) | 4 | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | 1 | -8 ▼ 714.4% | -8 ▲ 3.7% | 16 ▲ 304.7% | 27 ▲ 70.4% | -11 ▼ 141.2% | 12 ▲ 206.7% | 6 ▼ 51.3% | -23 ▼ 487.3% | |
| Total Expenses (incl. D&A & Interest) | 753 | 834 ▲ 10.8% | 706 ▼ 15.3% | 549 ▼ 22.4% | 840 ▲ 53.1% | 882 ▲ 5.0% | 789 ▼ 10.6% | 876 ▲ 11.0% | 958 ▲ 9.4% | |
| Material Cost % of RevenueDerived | 24.93% | 23.35% | 42.20% | 35.49% | 50.06% | 52.34% | 39.59% | 38.51% | 47.13% | |
| Employee Cost % of RevenueDerived | 5.29% | 5.56% | 5.04% | 5.81% | 2.82% | 2.66% | 3.10% | 3.22% | 3.18% | |
| Other Cost % of RevenueDerived | 6.48% | 5.20% | 4.60% | 4.56% | 3.48% | 3.96% | 4.13% | 4.25% | 4.37% | |
| Interest Coverage (x)Derived | -0.45x | -0.53x | 0.13x | -0.27x | 1.87x | 1.80x | 1.63x | 2.27x | 2.24x |
Sicagen India segment analysis : revenue and profit mix.
Disclosed business segments at Sicagen India with their share of revenue and profit, switchable between consolidated and standalone reporting.
Sicagen India discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Sicagen India Ltd.
Our AI distills the core fundamental drivers supporting Sicagen India Ltd, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
What you're getting.
No strengths or opportunities on record.
Key Risks.
No weaknesses or threats on record.
Flip Conditions.
Valuation risk. a P/E above 15 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
Sicagen India Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Sicagen India Ltd is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Sicagen India Ltd chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Sicagen India Ltd — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Sicagen India Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Sicagen India Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Sicagen India Ltd stood at 52.8% of traded volume, against a 20-day average of 61.0%.
Sicagen India announcements: results, concalls, ratings, M&A.
Filings Sicagen India sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Sicagen India files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 31 documents below.
Company Update
Notice to shareholders through Newspaper - requesting to register their e-mail id''s.
Insider Trading / SAST
Intimation of Trading Window closure for the quarter ended 30th June, 2026.
Insider Trading / SAST
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for…
Insider Trading / SAST
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for South…
Sicagen India dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Sicagen India has declared, sequenced by announce and record date.
Sicagen India corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Sicagen India Ltd: business, sector, key facts.
What Sicagen India Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Sicagen India Ltd is a listed Indian equity, listed as NSE: SICAGEN, BSE: 533014.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Aarvi Encon (AARVI) Share PricePeer
- ABM International (ABMINTLLTD) Share PricePeer
- Accuracy Shipping (ACCURACY) Share PricePeer
- Ace Integrated Solutions (ACEINTEG) Share PricePeer
- Allcargo Gati (ACLGATI) Share PricePeer
- Top Losers TodayScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Sicagen India Ltd (SICAGEN).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Sicagen India Ltd (SICAGEN)?
The current share price of Sicagen India Ltd (SICAGEN) is ₹53.55. Today, the stock has declined by ₹2.11 (3.79%), trading in a range of ₹52.88 to ₹57.00. The stock opened at ₹57.00 with a trading volume of 88,185 shares.
02Is Sicagen India Ltd stock a good investment for long-term?
Sicagen India Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹212.1 Cr., P/E ratio of 11.41, ROE of 3.74%, and ROCE of 5.95%. The dividend yield stands at 1.91%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Sicagen India Ltd stock?
The 52-week high price of Sicagen India Ltd (SICAGEN) is ₹74.06, while the 52-week low is ₹46.55. Currently trading at ₹53.55, the stock is 15.04% above its 52-week low and 27.69% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Sicagen India Ltd stock at the current price?
Whether to buy Sicagen India Ltd stock at ₹53.55 depends on multiple factors. The stock is currently trading with a P/E ratio of 11.41 and P/B ratio of 0.47. Today's performance shows a loss of 3.79%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Sicagen India Ltd and when is the next dividend?
Sicagen India Ltd offers a dividend yield of 1.91%, which means for every ₹100 invested at the current price of ₹53.55, you can expect to receive approximately ₹1.91 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Sicagen India Ltd?
Sicagen India Ltd's key financial metrics include: P/E Ratio: 11.41, P/B Ratio: 0.47, ROE: 3.74%, ROCE: 5.95%, Dividend Yield: 1.91%, EPS: ₹4.57, Book Value: ₹125.00, and Debt-to-Equity: 0.32. The company's market cap stands at ₹212.1 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Sicagen India Ltd stock performing today in the market?
Sicagen India Ltd stock opened at ₹57.00 and is currently trading at ₹53.55, showing a decline of ₹2.11 (3.79%). The intraday high is ₹57.00 and low is ₹52.88. The trading volume stands at 88,185 shares, indicating moderate market participation today.
08What is the P/E ratio of Sicagen India Ltd and what does it indicate?
Sicagen India Ltd has a Price-to-Earnings (P/E) ratio of 11.41, which means investors are willing to pay 11.41 for every ₹1 of earnings. With an EPS of ₹4.57, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Sicagen India Ltd (SICAGEN) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.